Literature DB >> 15925403

Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.

Thomas Lundqvist1.   

Abstract

This review aims to compare cognitive consequence between cannabis, and stimulants and heroin with regards to attention, memory and executive functions. The available studies using brain imaging techniques and neuropsychological tests show that acutely, all drugs create a disharmony in the neuropsychological network, causing a decrease of activity in areas responsible for short-term memory and attention, with the possible exception of heroin. Cannabis induces loss of internal control and cognitive impairment, especially of attention and memory, for the duration of intoxication. Heavy cannabis use is associated with reduced function of the attentional/executive system, as exhibited by decreased mental flexibility, increased perserveration, and reduced learning, to shift and/or sustain attention. Recent investigations on amphetamine/methamphetamine have documented deficits in learning, delayed recall, processing speed, and working memory. MDMA users exhibit difficulties in coding information into long-term memory, display impaired verbal learning, are more easily distracted, and are less efficient at focusing attention on complex tasks. The degree of executive impairment increases with the severity of use, and the impairments are relatively lasting over time. Chronic cocaine users display impaired attention, learning, memory, reaction time and cognitive flexibility. Heroin addiction may have a negative effect on impulse control, and selective processing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925403     DOI: 10.1016/j.pbb.2005.02.017

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  103 in total

Review 1.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

2.  Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution.

Authors:  Robert A Battisti; Steven Roodenrys; Stuart J Johnstone; Nicole Pesa; Daniel F Hermens; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2010-08-19       Impact factor: 4.530

3.  Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.

Authors:  April D Thames; Zanjbeel Mahmood; Alison C Burggren; Ahoo Karimian; Taylor P Kuhn
Journal:  AIDS Care       Date:  2015-12-23

4.  Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation.

Authors:  Michael J Wesley; Joshua A Lile; Colleen A Hanlon; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2015-12-22       Impact factor: 4.530

5.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

6.  Functional imaging of implicit marijuana associations during performance on an Implicit Association Test (IAT).

Authors:  Susan L Ames; Jerry L Grenard; Alan W Stacy; Lin Xiao; Qinghua He; Savio W Wong; Gui Xue; Reinout W Wiers; Antoine Bechara
Journal:  Behav Brain Res       Date:  2013-09-09       Impact factor: 3.332

7.  AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.

Authors:  Mark D Black; Rachel J Stevens; Nancy Rogacki; Robert E Featherstone; Yaw Senyah; Odessa Giardino; Beth Borowsky; Jeanne Stemmelin; Caroline Cohen; Philippe Pichat; Michal Arad; Segev Barak; Amaya De Levie; Ina Weiner; Guy Griebel; Geoffrey B Varty
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

8.  Cocaine and Pavlovian fear conditioning: dose-effect analysis.

Authors:  Suzanne C Wood; Jonathan Fay; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

9.  Expectancy change and adolescents' intentions to use marijuana.

Authors:  Jessica J Skenderian; Jason T Siegel; William D Crano; Eusebio E Alvaro; Andrew Lac
Journal:  Psychol Addict Behav       Date:  2008-12

10.  Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice.

Authors:  Adriana M Marques; Michele V Macena; Aline R Cardoso; Camila S O Hammes; Fernanda M L Pinheiro; Newton G Castro; Gilda A Neves
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.